{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Ledgewood",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "94378",
      "recalling_firm": "Imprimis NJOF, LLC",
      "address_1": "1705 Route 46 Ste 6B",
      "address_2": "",
      "postal_code": "07852-9720",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S. Nationwide",
      "recall_number": "D-0476-2024",
      "product_description": "Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ 07852, NDC 71384-340-08",
      "product_quantity": "3320 bottles",
      "reason_for_recall": "Subpotent Drug",
      "recall_initiation_date": "20240410",
      "center_classification_date": "20240429",
      "report_date": "20240508",
      "code_info": "Lot #: 23JUN031; Exp. 07/03/2024",
      "more_code_info": ""
    }
  ]
}